咨询热线:

020-3107 8154

Staurosporine 星形孢菌素; Antibiotic AM-2282; STS; AM-2282

Staurosporine 是一种有效,ATP 竞争性的,非选择性蛋白激酶抑制剂,抑制 PKC,PKA,c-Fgr,和 Phosphorylase kinase 的 IC50 分别为 6 nM,15 nM,2 nM,3 nM。Staurosporine 也抑制 TAOK2,IC50 值 3 μM。Staurosporine 是一个凋亡诱导剂。

  • 货号:
    TK0186
  • 规格:
    1mg
    2mg
    5mg
    10mg
  • 价格:
    0.00

产品参数

CAS No.62996-74-1
生物活性Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively. Staurosporine also inhibits TAOK2 with an IC50 of 3 μM. Staurosporine is an apoptosis inducer.
分子式C28H26N4O3
分子量466.53
运输条件Room temperature in continental US; may vary elsewhere.
储存条件Powder -20°C 3 years
溶解性数据DMSO : 62.5 mg/mL (133.97 mM; Need ultrasonic)
体内研究The inhibitory effect of Staurosporine is statistically significant at around Wk 10 of tumor promotion. Although statistically significant inhibition is not obtained with 10 ng of Staurosporine in later weeks of the experiment, a decreasing tendency in the percentages of tumor bearing mice and in average numbers of tumors per mouse is apparent. Thus, Staurosporine slightly inhibits tumor promotion of Teleocidin, even at the dose at which Staurosporine itself induced tumors. Staurosponne (0.05 and 0.1 mg/kg intraperitoneal) attenuates the impaired perlormance of water maze and passive avoidance tasks, even though the drug administration began 2 weeks after the lesion. Moreover, Staurosporine (0.1 mg/kg) partially reversed the decrease of choline acetyltransferase activity in the fronto-parietal cortex induced by basal forebrain-lesion. These results suggest that Staurosporine attenuates impairment of learning through reversal of damage to cholinergic neurons induced by basal forebrain-lesion.
体外研究Staurosporine, widely used as a protein kinase C (PKC) inhibitor with a broad spectrum of activity, is an alkaloid isolated from the culture broth of Streptomyces staurospores. MC3T3E-1 osteoblasts, expose to Staurosporine (100 nM) for 12 h, release an amount of LDH (12.4±3.1%) that is similar to that release by the control cells(10.0±2.4%), indicating the relative absence of lytic death, which occurs in necrosis. In addition, treatment with Staurosporine (100 nM) results in morphological changes, characteristic of apoptosis: a brightblue fluorescent condensed nuclei seen through a fluorescence microscope after Hoechst 33258-staining, and a reduction of cell volume.
文献•Nature. 2021 Mar;591(7850):477-481. •Cell. 2018 Sep 6;174(6):1477-1491.e19. •Cell Res. 2018 Dec;28(12):1171-1185. •Cell Stem Cell. 2021 Sep 14;S1934-5909(21)00343-X. •Signal Transduct Target Ther. 2020 Oct 9;5(1):235. •Autophagy. 2019 Nov;15(11):1990-2001. •J Am Chem Soc. 2018 Feb 7;140(5):1863-1869. •Cancer Res. 2013 Apr 15;73(8):2574-86. •Theranostics. 2020 May 22;10(15):6825-6838. •Cell Mol Immunol. 2020 Aug;17(8):881-883. •Cell Rep. 2020 Mar 31;30(13):4370-4385.e7. •Cell Death Dis. 2021 Nov 10;12(11):1070. •Sci Signal. 2021 Jun 8;14(686):eabc7405. •J Colloid Interface Sci. 2019 May 1;543:96-105. •Free Radic Biol Med. 2020 May 20;152:227-234. •Development. 2021 Jul 15;148(14):dev199461. •Int J Biol Sci. 2022; 18(2):717-730. •Eur J Med Chem. 2019 Nov 1;181:111552. •Cell Commun Signal. 2021 Oct 11;19(1):103. •J Cell Mol Med. 2018 Dec;22(12):6039-6054. •Cell Death Discov. 2021 Jul 27;7(1):196. •ACS Chem Biol. 2017 May 19;12(5):1245-1256. •Life Sci. 2021 Feb 1;119139. •Int Immunopharmacol. 2017 Sep;50:30-37. •Molecules. 2019 May 25;24(10):2004. •Sci Rep. 2015 Aug 3;5:12728. •Biochim Biophys Acta. 2018 Aug;1864(8):2600-2609. •Arch Biochem Biophys. 2019 Aug 15;671:42-51. •Chem Res Toxicol. 2019 Sep 16;32(9):1871-1879. •Future Med Chem. 2017 Jan;9(1):7-24. •Neuroscience. 2017 Dec 4;365:217-225. •Biochem Biophys Res Commun. 2018 Sep 3;503(1):297-303. •Virus Res. 2019 May;265:104-114. •Mol Inform. 2018 Nov;37(11):e1800031. •Bioorg Med Chem Lett. 2019 Feb 15;29(4):549-555. •Med Chem Res. 2017, 26(9), 2007-2014. •Vet Comp Oncol. 2019 Jun;17(2):174-183. •Patent. US20210379056A1. •Fish Shellfish Immunol. 2020 Feb;97:390-402. •Chinese Pharmacological Bulletin. 2017, 33(12): 1661-1667.
纯度及产品资料98%